Greg Frieherr | Authors

December 29, 2010

Research from Japan documenting remarkable survival rates among patients with inoperable lung cancer may only hint at the potential of proton-beam radiation therapy. The study out of the Proton Medical Research Center in Tennoudai, Japan, documented high survival rates for 55 patients suffering from stage I inoperable non-small-cell lung cancer.

December 23, 2010

The key to effective treatment of squamous lung cell lung cancer in smokers may be at hand.

December 08, 2010

A new hybrid technology emerged at radiology’s mega conference in Chicago earlier this month, one that may dislodge decade-old PET/CT from its prominent berth for the diagnosis and monitoring of cancer patients. This new modality combines the positron-imaging component of PET/CT with oncology’s premier anatomic modality, MR, opening the door to cancer images with unprecedented clarity and clinical value.

November 29, 2010

Pathologies such as infections, or even tumors, crop up from time to time in patients examined for entirely unrelated issues. These "incidental findings"can put doctors-and patients-in a tight spot. How do they proceed with the patient, knowing that many of the asymptomatic signs of disease may never lead to clinical problems, or may simply be false positives?

November 29, 2010

The search for a magic bullet against cancer historically has glowed bright then dimmed, depending on the stage of discovery. Developments surrounding monoclonal antibodies and angiogenesis inhibitors have followed this cycle, as exuberance for their potential has bowed to the nuances that underlie the complex mechanisms on which they depend.

November 05, 2010

McKesson plans to spend more than $2 billion to purchase the largest community-based cancer treatment and research network in America.

October 27, 2010

Research from Japan documenting remarkable survival rates among patients with inoperable lung cancer may only hint at the potential of proton beam therapy.

October 21, 2010

Cancer care experts describe the building blocks for creating a survivorship program.

October 19, 2010

The search for a magic bullet against cancer historically has glowed bright then dimmed, depending on the stage of discovery. Developments surrounding monoclonal antibodies and angiogenesis inhibitors have followed this cycle, as exuberance for their potential has bowed to the nuances that underlie the complex mechanisms on which they depend.

September 21, 2010

On average, 11% of cancer patients drop out of hospice care, according to research conducted at the Mount Sinai School of Medicine. Many of these patients are in for rough sledding.